• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Fitbit

Fitbit wins U.S., EU regulatory approval for ECG app

September 14, 2020 By Sean Whooley

Fitbit (NYSE:FIT) announced today that it received FDA 510(k) and CE Mark clearance for its electrocardiogram (ECG) app. San Francisco-based Fitbit’s ECG app is designed to assess heart rhythm for atrial fibrillation (AFib), offering a simple method for on-the-spot readings, including whenever a user notices any unusual cardiac symptoms, according to a news release. The Fitbit […]

Filed Under: 510(k), Cardiovascular, Featured, Food & Drug Administration (FDA), Health Technology, Patient Monitoring, Regulatory/Compliance, Software / IT Tagged With: CE Mark, FDA, Fitbit

NASA, Fitbit gain EUAs for COVID-19 devices

June 3, 2020 By Sean Whooley

The FDA granted emergency use authorization (EUA) for emergency COVID-19 ventilator devices developed by Nasa and Fitbit (NYSE:FIT). According to the FDA’s ongoing list of devices granted EUAs, both devices were authorized on June 1. NASA’s VITAL (ventilator intervention technology accessible locally) compressor and the Fitbit Flow are the latest of a few ventilator alternatives to […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Respiratory Tagged With: coronavirus, COVID-19, FDA, Fitbit, NASA

Fitbit launches wearable AFib detection study

May 11, 2020 By Danielle Kirsh

Fitbit (NYSE:FIT) recently announced it launched its first large-scale, virtual study to validate the use of its wearables in atrial fibrillation detection. The Fitbit Heart Study is part of Fitbit’s larger strategy to make easy-to-use tools for the detection of a range of conditions. The goal of the study is to enroll hundreds of thousands of […]

Filed Under: Cardiovascular, Featured Tagged With: Fitbit

Google to pay more than $2B for Fitbit

November 1, 2019 By Brad Perriello

Fitbit (NYSE:FIT) today confirmed the rumor of an acquisition by Google parent Alphabet (NSDQ:GOOG), revealing that it accepted a $7.35-per-share cash offer worth about $2.1 billion. “More than 12 years ago, we set an audacious company vision – to make everyone in the world healthier. Today, I’m incredibly proud of what we’ve achieved towards reaching that goal. We […]

Filed Under: Digital Health, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Alphabet (Google), Fitbit

Report: Google parent Alphabet eyes Fitbit

October 29, 2019 By Sean Whooley

Google parent Alphabet (NSDQ:GOOG) reportedly made an offer to acquire Fitbit (NYSE:FIT) in an attempt to work its way into the smartwatch and fitness tracker market. There is not any certainty of a deal as of yet and no financial terms were shared, according to a report from Reuters, which cited “people familiar with the matter.” […]

Filed Under: Featured, Mergers & Acquisitions, Software / IT, Wall Street Beat Tagged With: Alphabet (Google), Fitbit

Fitbit inks cardiovascular monitoring deal with pharma alliance

October 17, 2019 By Sean Whooley

The Bristol-Myers Squibb (NYSE:BMY)-Pfizer (NYSE:PFE) Alliance said today that it is working with Fitbit (NYSE:FIT) to improve earlier detection of atrial fibrillation in individuals with an increased risk of stroke. Fitbit and the alliance plan to work together on the development of educational content and guidance in support of people at increased risk for Afib. Fitbit is seeking […]

Filed Under: Business/Financial News, Cardiovascular, Software / IT Tagged With: Bristol-Myers Squibb Co., Fitbit, Pfizer

Fitbit adds FibriCheck afib detector

September 25, 2019 By Sean Whooley

Fitbit (NYSE:FIT) and FibriCheck said yesterday that they inked a deal to enable European users to monitor their heart rhythm for irregularities directly from a Fitbit smartwatch. Users in Belgium, Holland, Ireland and the U.K. are affected by the partnership, which combines the CE-marked FibriCheck software with the Fitbit smartwatch technology to check for irregularities such […]

Filed Under: Cardiovascular, Digital Health, Featured Tagged With: FibriCheck, Fitbit

Report: Murder victim’s Fitbit helps police charge suspect

October 5, 2018 By Fink Densford

Heart rate tracking data on a Fitbit fitness tracker has helped police investigators identify and charge a murder suspect, according to a New York Times report. Though the devices are intended mainly to monitor health and motivate users to be more active, heart rate data, sleeping patterns and physical exertion measurements can be used to […]

Filed Under: Diagnostics, Digital Health, Legal News Tagged With: Fitbit

HRS 2018 Roundup: Device-related blood clots with Boston Scientific’s Watchman implant

May 11, 2018 By Brad Perriello

Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8

Filed Under: Cardiovascular Tagged With: Apple, Bardy Diagnostics, Boston Scientific, Fitbit, HRS 2018, Impulse Dynamics, Imricor Medical Systems Inc., medicalgorithmics, Medtronic, Preventice, samsung

Fitbit unveils array of new apps from health partners

May 7, 2018 By Sarah Faulkner

Fitbit (NYSE:FIT) revealed today a suite of new apps and clock faces designed to help people manage their health, including a glucose monitoring app from Dexcom (NSDQ:DXCM) that is slated to launch in the second half of 2018. The Las Vegas-based company also announced programming from Diplomat Pharmacy, Humana (NYSE:HUM), One Drop and Walgreens. Get the full story at our sister site, Drug […]

Filed Under: Patient Monitoring, Software / IT, Wall Street Beat Tagged With: Dexcom, Fitbit, Humana, One Drop

Google, Fitbit ink collab healthcare deal, look to challenge Apple Watch

May 1, 2018 By Fink Densford

Fitbit (NYSE:FIT) yesterday announced plans for a health-care collaboration with Google (NSDQ:GOOG), giving Apple (NSDQ:AAPL) and its Apple Watch more competition in the mobile health monitor market. The wearable developer plans to use Google’s Cloud healthcare API for further healthcare system integration, which could allow FitBit activity data to be integrated with electronic medical records for more […]

Filed Under: Business/Financial News, Digital Health, Patient Monitoring Tagged With: Alphabet (Google), Apple, Fitbit

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS